Report Highlights
The Global Mass Spectrometry and Chromatography in Diagnostics Market Expected to Reach $1,863.8 Million by 2033
Global Mass Spectrometry and Chromatography in Diagnostics Market Industry Overview
The global mass spectrometry and chromatography in diagnostics market was valued at $743.1 million in 2023 and is expected to reach $1,863.8 million by 2033, growing at a CAGR of 9.92% between 2024 and 2033. The mass spectrometry (MS) and chromatography markets are critical components of the broader analytical and life sciences instrumentation sector. Both technologies offer sophisticated methods for the separation, identification, and quantification of chemical and biological substances and have been instrumental in driving advances across a variety of fields, including pharmaceuticals, environmental monitoring, diagnostics, and food safety, among others. For diagnostics applications, these technologies are mostly not used in isolation but are integrated into workflows. For instance, liquid chromatography-mass spectrometry combines the separation capabilities of liquid chromatography with the mass analysis power of mass spectrometry. This integration is particularly effective in complex sample analysis, where components need to be separated before their mass and structure can be determined. Such hybrid systems are critical in clinical settings for the high-throughput analysis of patient samples, offering a comprehensive understanding that guides diagnosis and treatment. The key applications of mass spectrometry and chromatography in diagnostics include vitamin profiling and hormone profiling, among others.
Market Introduction
The mass spectrometry and chromatography in diagnostics market is experiencing rapid growth, driven by multiple benefits offered by the technologies as compared to the traditional immunoassays, and continuous technological advancements in these technologies are further advancing their adoption. However, the high cost of acquisition of instrumentations, as well as the dearth of skilled professionals, is expected to hinder the growth of the global mass spectrometry and chromatography in diagnostics market.
Furthermore, there has been a shift toward the utilization of liquid chromatography-tandem mass spectrometry (LC-MS/MS) as a standard technique in diagnostics. The growing preference for LC-MS/MS in diagnostics is driven by its unparalleled analytical advantages, which include exceptional specificity, sensitivity, and the ability to conduct multiplex testing, qualities that are indispensable for complex diagnostic tasks. In addition to this, the integration of automated sample preparation systems in mass spectrometry-based diagnostics marks a pivotal advancement in clinical laboratory operations. This trend will continue to expand, driven by the increasing demands for faster, more accurate diagnostic testing and the ongoing advancements in technology.
Industrial Impact
This technology has a pivotal role in diagnostics applications such as therapeutic drug monitoring, vitamin analysis, hormone profiling, newborn screening, and infectious diseases, among others.
Market Segmentation:
Segmentation 1: by Product Type
- Sample Preparation
- Mass Spectrometry and Chromatography
Mass Spectrometry and Chromatography Segment to Dominate the Mass Spectrometry and Chromatography in Diagnostics Market (by Product Type)
The mass spectrometry and chromatography segment is poised to dominate the mass spectrometry and chromatography in diagnostics market based on product type. This dominance has been driven by the high cost of the instrumentations of mass spectrometry and chromatography and the recurring use of consumables in diagnostics.
Segmentation 2: by Application Type
- Therapeutic Drug Monitoring
- Vitamins
- Hormones
- Methylmalonic Acid
- Immunosuppressants
- Others
Others Segment to Dominate the Mass Spectrometry and Chromatography in Diagnostics Market (by Application Type)
The others segment is positioned to dominate the mass spectrometry and chromatography in diagnostics market by application type. This predominance is largely due to the fact that newborn screening was one of the earliest applications of mass spectrometry and chromatography in diagnostics. These technologies have been integral to this field for a long time, making a significant contribution to the market.
Segmentation 3: by Sample Type
- Blood
- Urine
- Serum
- Plasma
- Saliva
Serum to Dominate the Mass Spectrometry and Chromatography in Diagnostics Market (by Sample Type)
The serum segment is positioned to dominate the mass spectrometry and chromatography in diagnostics market based on sample type due to its suitability for a broad spectrum of applications, from hormone profiling to vitamin analysis. This makes serum an ideal sample type for precise and comprehensive diagnostic tests.
Segmentation 4: by Testing Type
- Laboratory-Developed Tests
- Commercial Assays
Laboratory-Developed Tests to Dominate the Mass Spectrometry and Chromatography in Diagnostics Market (by Testing Type)
The laboratory-developed tests segment is positioned to dominate the mass spectrometry and chromatography in diagnostics market by testing type. On the other hand, the commercial assay segment is expected to be the fastest-growing segment, with a CAGR of 10.40% in the forecast period 2024-2033.
Segmentation 5: by Region
- North America
- o U.S.
- o Canada
- Europe
- o Germany
- o U.K.
- o Spain
- o Italy
- o France
- o Rest-of-Europe
- Asia-Pacific
- o China
- o Japan
- o India
- o Rest-of-Asia-Pacific
- Latin America
- o Brazil
- o Mexico
- o Rest-of-Latin America
- Middle East and Africa
- o GCC Countries
- o South Africa
- o Rest-of-Middle East and Africa
The global mass spectrometry and chromatography in diagnostics market (by region) has been dominated by North America, which held 45.10% of the market share in 2023 and is anticipated to retain its position in the market during the forecast period. The region boasts an advanced healthcare infrastructure, particularly in the U.S., which facilitates the adoption of cutting-edge medical technologies, including mass spectrometry and chromatography. Additionally, North America is the hub to many leading companies in the mass spectrometry and chromatography in diagnostics market, such as Agilent Technologies, Inc., Thermo Fisher Scientific Inc., and SCIEX (Danaher Corporation), among others whose strong presence and continuous innovation drive growth of the mass spectrometry and chromatography in diagnostics market.
Recent Developments in the Mass Spectrometry and Chromatography in Diagnostics Market
- In June 2024, Shimadzu Corporation introduced the new LCMS RX series of triple quadrupole mass spectrometry instruments.
- In October 2023, Revvity, Inc. announced a value-added distribution agreement with SCIEX. This strategic agreement was aimed at enhancing Revvity's newborn screening products by integrating SCIEX’s innovative mass spectrometry solutions, leveraging expertise and resources from both companies.
- In August 2023, Thermo Fisher Scientific commercially launched the EXENT Solution upon receiving IVDR certification. This fully automated, integrated mass spectrometry system is designed to revolutionize the diagnosis and evaluation of patients suffering from monoclonal gammopathies, including multiple myeloma.
- In April 2023, Waters Corporation unveiled its next-generation Xevo TQ Absolute IVD mass spectrometer, expanding its MassTrak IVD LC-MS/MS Systems family for clinical diagnostic applications.
- In June 2022, PerkinElmer launched the GC 2400 Platform, an advanced, automated gas chromatography (GC), headspace sampler, and GC/mass spectrometry (GC/MS) solution designed to help lab teams simplify lab operations, drive precise results, and perform more flexible monitoring.
Demand – Drivers, Challenges, and Opportunities
Market Demand Drivers:
Shift from Traditional Methods to Mass Spectrometry and Chromatography in Clinical Diagnostics: The growing shift toward mass spectrometry and chromatography in clinical diagnostics represents a significant growth opportunity for the global mass spectrometry and chromatography in diagnostics market. As laboratories increasingly recognize the limitations of traditional immunoassays, the demand for more precise and efficient diagnostic technologies such as LC-MS/MS is expected to expand even more. This trend has been supported by the technology's ability to deliver accurate, robust, and cost-efficient results, which is crucial for improving patient outcomes and operational efficiency in clinical settings.
Market Challenges:
High Initial Set-Up Cost: The substantial upfront and recurring costs associated with mass spectrometry and chromatography systems present a formidable challenge for their broader adoption in clinical diagnostics. These financial barriers are particularly impactful for smaller laboratories and healthcare facilities with tight budgets, limiting their ability to invest in advanced diagnostic technologies.
Market Opportunities:
Focus on Emerging Markets for Expansion of Mass Spectrometry and Chromatography in Diagnostics: The global mass spectrometry and chromatography in diagnostics market presents substantial opportunities for growth in emerging countries, particularly through strategic focus on market expansion, growth opportunities in emerging economies, and the development of customized solutions. By focusing on affordability and accessibility, developing local partnerships and training programs, navigating regulatory requirements, and creating integrated diagnostic solutions, companies can unlock significant growth opportunities in the untapped markets of emerging countries.
How can this Report add Value to an Organization?
Product/Innovation Strategy: The global mass spectrometry and chromatography in diagnostics market has been segmented based on various categories, such as by product type, application type, sample type, testing type, and region.
Growth/Marketing Strategy: Partnerships, alliances, fundings, new offerings, and business expansions together accounted for the maximum number of key developments of the total developments in the mass spectrometry and chromatography in diagnostics market between January 2015 and June 2024.
Competitive Strategy: The global mass spectrometry and chromatography market consists of various public and few private companies. Key players in the mass spectrometry and chromatography in diagnostics market analyzed and profiled in the study involve established players that offer various kinds of products.
Report Synopsis
| Report Metrics | Details |
| Base year considered | 2024 |
| Forecast period considered | 2024-2033 |
| Base year market size | $795.9 Million in 2024 |
| Market size forecast | $1,863.8 Million by 2033 |
| Growth rate | 9.92% |
| Units considered | $ Million |
| Segments covered | By Product Type, By Application Type, By Sample Type, By Testing Type, By Region |
| Industry covered | BIS Healthcare |
| Regions covered | North America, Europe, Asia-Pacific, Latin America, Middle East and Africa |
| Countries covered | U.S., Canada, Germany, U.K., Spain, Italy, France, Rest-of-Europe, China, Japan, India, Rest-of-Asia-Pacific , Brazil, Mexico, Rest-of-Latin America, GCC Countries, South Africa, Rest-of-Middle East and Africa |
| Companies studied |
|
Methodology
Key Considerations and Assumptions in Market Engineering and Validation
- The base year considered for the calculation of the market size is 2023. A historical year analysis has been done for the period FY2018-FY2022. The market size has been estimated for FY2023 and projected for the period FY2024-FY2033.
- The scope of this report has been carefully derived based on interactions with experts in different companies across the world. This report provides a market study of mass spectrometry and chromatography in diagnostics.
- The market contribution of mass spectrometry and chromatography in diagnostics anticipated to be launched in the future has been calculated based on the historical analysis of the solutions.
- Revenues of the companies have been referenced from their annual reports FY2018-FY2023.
- The market has been mapped based on the available mass spectrometry and chromatography in diagnostics products. All the key companies with significant offerings in this field have been considered and profiled in this report.
Primary Research:
The primary sources involve industry experts in mass spectrometry and chromatography in diagnostics. Key opinion leaders (KOLs) such as CEOs, vice presidents, marketing directors, and technology and innovation directors have been interviewed to obtain and verify both qualitative and quantitative aspects of this research study.
The key data points taken from the primary sources include:
- validation and triangulation of all the numbers and graphs
- validation of the report’s segmentation and key qualitative findings
- understanding the competitive landscape and business model
- current and proposed production values of a product by market players
- validation of the numbers of the different segments of the market in focus
- percentage split of individual markets for regional analysis
Secondary Research:
Open Sources
- Certified publications, articles from recognized authors, white papers, directories, and major databases, among others
- Annual reports, SEC filings, and investor presentations of the leading market players
- Company websites and detailed study of their product portfolio
- Gold standard magazines, journals, white papers, press releases, and news articles
- Paid databases
The key data points taken from the secondary sources include:
- segmentations and percentage shares
- data for market value
- key industry trends of the top players of the market
- qualitative insights into various aspects of the market, key trends, and emerging areas of innovation
- quantitative data for mathematical and statistical calculations
Key Market Players and Competition Synopsis
The companies profiled have been selected based on inputs gathered from primary experts and analyzing company coverage, product portfolio, and market penetration.
The mass spectrometry and chromatography in diagnostics market (by product type) dominates by mass spectrometry and chromatography segment, securing a share of 85.34% in 2023. Sample preparation, on the other hand, accounted for approximately 14.66% of the market share in 2023.
Some prominent names established in this market are:
- Agilent Technologies, Inc.
- Thermo Fisher Scientific Inc.
- Waters Corporation
- Tecan Group Ltd.
- Danaher Corporation
- Shimadzu Corporation
- Merck KGaA
- Bio-Rad Laboratories, Inc.
- PerkinElmer Inc.
- Promega Corporation
- Restek Corporation
- Gerstel GmbH & Co. KG
- Phenomenex Inc. (Danaher Corporation)
- Bruker Corporation
- New England Biolabs
- Hamilton Company
- Avantor, Inc. (VWR International, LLC.)
- Chromsystems Instruments & Chemicals GmbH
- RECIPE Chemicals + Instruments GmbH
- Zivak
- SENTINEL CH. SpA
BIS Research is a global B2B market intelligence and advisory firm focusing on those emerging technological trends which are likely to disrupt the dynamics of the market.
With over 150 market research reports published annually, BIS Research focuses on high technology verticals such as 3D Printing, Advanced Materials and Chemicals, Aerospace and Defense, Automotive, Healthcare, Electronics and Semiconductors, Robotics and UAV, and other emerging technologies.
Our in-depth market intelligence reports focus on the market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More